SF-BARI Score for Assessment of Long-Term Results in Patients with BMI ≥ 50 kg/m2 Submitted to Roux-en-Y Gastric Bypass or Sleeve Gastrectomy

  1. André Costa-Pinho
  2. João Araújo-Teixeira
  3. Sara Rodrigues
  4. Hugo Santos-Sousa
  5. Fernando Resende
  6. John Preto
  7. Eduardo Lima-da-Costa
Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background

Patients with a body mass index (BMI) ≥ 50 kg/m 2 present significant challenges in terms of treatment options, and data on long-term outcomes following metabolic and bariatric surgery (MBS) in this population remain limited. This study aims to explore the long-term outcomes of Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) in patients with BMI ≥ 50 kg/m 2 , utilizing the Swiss-Finnish Bariatric Metabolic Outcome Score (SF-BARI Score)—a comprehensive tool that incorporates multiple outcome dimensions—and to identify factors that may influence these outcomes.

Methods

Retrospective cohort study of patients with BMI ≥ 50 kg/m 2 submitted to RYGB or SG between January 2010 and September 2021, with more than 5 years of follow-up. Several data were collected, and the SF-BARI score was calculated and analyzed. Statistical analysis was performed to identify variables that influenced the score.

Results

We identified 89 patients with long-term follow-up (mean 96.6 months, SD 18.9) after RYGB or SG. The mean SF-BARI score was 94.2 (SD 29.5), with most patients’ outcomes categorized as good. Seventy-six (85.4%) patients had %TWL ≥ 20, but only 34.8% of patients had a final BMI < 35 kg/m 2 . Statistical analysis revealed that younger patients have higher SF-BARI scores related to comorbidities improvement.

Conclusion

Our findings suggest that both RYGB and SG lead to satisfactory long-term outcomes for treatment of patients with BMI ≥ 50 kg/m 2 , according to the SF-BARI score. However, only one-third achieved a BMI < 35 kg/m 2 . Younger patients seem to achieve better results, particularly in comorbidity improvements. MBS outcomes should be reported in a standardized manner, addressing key components such as weight loss, improvement in comorbidities, complications, and quality of life.

Article activity feed

  1. Version published to 10.1007/s11695-025-07973-8
  2. Version published to 10.21203/rs.3.rs-5026667/v1 on Research Square